Rapid determination of minocycline in pharmaceutical formulations and human urine/serum samples based on the minocycline-europium-sodium dodecylbenzene sulfonate luminescence system

Analytical Letters

Volumn 42, Issue 2, 2009, Pages 228-242

  Chen, Chuanyan ^a   Guo, Changchuan ^a   Wang, Lei ^a   Jiang, Wei ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Determination; Europium; Luminescence; Minocycline

Indexed keywords

EID: 61649087272     PISSN: 00032719     EISSN: 1532236X     Source Type: Journal    
DOI: 10.1080/00032710802585741     Document Type: Article

References (23)

1. Araujoa, M.V.F., Ifaa, D.R., Ribeiroa, W., Moraes, M.E., Moraes, M.O., and Nucci, G. 2001. Determination of minocycline in human plasma by high-performance liquid chromatography coupled to tandem mass spectrometry: application to bioequivalence study. J. Chromatogr. B, 755: 1-7.
2. Chen, M., Ona, V.O., Li, M., Ferrante, R.J., Fink, K.B., Zhu, S., Bian, J., Guo, L., Farrell, L.A., Hersch, S.M., Hobbs, W., Vonsattel, J.P., Cha, J.H., and Friedlander, R.M. 2000. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat. Med., 6: 797-801.
3. Ding, F., Zhao, H.C., Jin, L.P., and Zheng, D. 2006. Study of the influence of silver nanoparticles on the second-order scattering and the fluorescence of the complexes of Tb(III) with quinolones and determination of the quinolones. Anal. Chim. Acta, 566: 136-143.
4. Du, Y., Ma, Z., Lin, S., Dodel, R.C., Gao, F., Bales, K.R., Triarhou, L.C., Chernet, E., Perry, K.W., Nelson, D.L., Luecke, S., Phebus, L.A., Bymaster, F.P., and Paul, S.M. 2001. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc. Natl. Acad. Sci. USA, 98: 14669-14674.
5. Guo, C.C., Dong, P., Chu, Z.J., Wang, L., and Jiang, W. 2008. Rapid determination of gatifloxacin in biological samples and pharmaceutical products using europium-sensitized fluorescence spectrophotometry. Luminescence, 23: 7-13.
6. Hains, B.C. and Waxman, S.G. 2006. Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J. Neurosci., 26: 4308-4317.
7. Jiang, C.Q. and Zhang, N. 2004. Enzyme-amplified lanthanide luminescence based on complexation reaction - a new technique for the determination of doxycycline. J. Pharm. Biomed. Anal., 35: 1301-1306.
8. Kraus, R.L., Pasieczny, R., Willingham, K.L., Turner, M., Jiang, A., and Trauger, J. 2005. Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity. J. Neurochem., 94: 819-827.
9. 3+ and its analytical application. J. Lumines, 96: 201-209.
10. Liu, S., Yang, J.H., Wu, X., Wang, F., Wang, F., Jia, Z., and Mao, L. 2004. Study on the interaction between protein and Eu(III)-chlorotetracycline complex and the determination of protein using the fluorimetric method. Luminescence, 19: 352-357.
11. Lovic, M. and Caccia, S. 2003. Liquid chromatographic determination of minocycline in brain-to-plasma distribution studies in the rat. J. Chromatogr. B, 791: 337-343.
12. Marczynski, S. 2000. Chemiluminescent method for determination of tetracycline, chlortetracycline, minocycline, doxycycline, and demeclocycline. Biopolymers, 57: 365-372.
13. Mascher, H.J. 1998. Determination of minocycline in human plasma by high performance liquid chromatography with UV detection after liquid-liquid extraction. J. Chromatogr. A, 812: 339-342.
14. Milane, A., Fernandez1, C., Bensimon, G., Meininger, V., and Farinotti, R. 2007. Simple liquid chromatographic determination of minocycline in brain and plasma. Chromatographia, 65: 277-281.
15. Orti, M., Audran, M., Gibert, P., Bougard, G., and Bressolleb, F. 2000. High-performance liquid chromatographic assay for minocycline in human plasma and parotid saliva. J. Chromatogr. B, 738: 357-365.
16. Peng, P., Hou, F., and Jiang, C.Q. 2006. Highly sensitive spectrofluorimetric determination of trace amounts NADP using Europium ion-doxycycline complex probe. Spectrochim. Acta Part A, 65: 62-66.
17. Prasad, A.V.S.S., Lakshmi, C.S.R., Sastry, C.S.P., and Uppuleti, V. P. 2002. Determination of minocycline by oxidative coupling and diazocoupling reactions in pharmaceutical formulations. J. Pharm. Biomed. Anal., 30: 491-498.
18. Tanase, I.G., David, I.G., Radu, G.L., Iorgulescu, E.E., and Litescu, S. 1998. Electrochemical determination of minocycline in pharmaceutical preparations. Analusis, 4: 175-179.
19. Tikka, T., Fiebich, B.L., Goldsteins, G., Keinanen, R., and Koistinaho, J. 2001. Minocycline, a tetracycline derivate, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J. Neurosci., 15: 2580-2588.
20. Wang, T. and Jiang, C.Q. 2006. Spectrofluorimetric determination of lecithin using a tetracycline-europium probe. Anal. Chim. Acta, 561: 204-209.
21. Yrjanheikki, J., Tikka, T., Keinanen, R., Goldsteins, G., Chan, P.H., and Koistinaho, J. 1999. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc. Natl. Acad. Sci. USA, 96: 13496-13500.
22. Yuan, J., Wang, G., Majima, K., and Matsumoto, K. 2001. Synthesis of a terbium fluorescent chelate and its application to time-resolved fluoroimmunoassay. Anal. Chem., 73: 1869-1876.
23. Zhu, S., Stavrovskaya, I.G., Drozda, M., Kim, B.Y., Ona, V., Li, M., Sarang, S., Liu, A.S., Hartley, D.M., Wu, D.C., Gullans, S., Ferrante, R.J., Przedborski, S., Kristal, B.S., and Friedlander, R.M. 2002. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature, 417: 74-78.